THE EFFECTS OF ASPIRIN AND DIPYRIDAMOLE ON THE METABOLISM OF ARACHIDONIC ACID IN HUMAN PLATELETSVOTILA P; DAHL ML; MATINTALO M et al.1983; PROSTAGLANDINS, LEUKOTRIENES AND MEDICINE; ISSN 0262-1746; GBR; DA. 1983; VOL. 11; NO 1; PP. 73-82; BIBL. 15 REF.Article

DEUX OBSERVATIONS D'AGRANULOCYTOSE AIGUE AU COURS D'UN TRAITEMENT ANTI-AGREGANT PAR LA TICLOPIDINECHOMIENNE C; BAUMELOU E; RIO B et al.1983; REVUE DE MEDECINE (PARIS); ISSN 0035-1512; FRA; DA. 1983; VOL. 24; NO 13; PP. 589-590; ABS. ENG; BIBL. 3 REF.Article

COMPARISON BETWEEN THE ANTIAGGREGATINE EFFECT OF TICLOPIDINE IN WHOLE BLOOD, PLATELET-RICH PLASMA AND WASHED PLATELETS OF THE RATRANDON J; LEFORT J; VARGAFTIG BB et al.1982; THROMBOSIS RESEARCH; ISSN 0049-3848; USA; DA. 1982; VOL. 26; NO 1; PP. 13-20; BIBL. 19 REF.Article

LES ANTIAGREGANTS PLAQUETTAIRESREY JL; BOISSELIER P; SALLE P et al.1982; REV. MED. PICARDIE; ISSN 0301-116X; FRA; DA. 1982; VOL. 10; NO 3; PP. 91-93; BIBL. 4 REF.Article

CHEMICAL APPROACH TO ASPIRIN HYPERSENSITIVITYRAMANJANEYULU R; MADYASTHA KM; BHATTACHARYYA PK et al.1981; BIOCHEM. BIOPHYS. RES. COMMUN.; ISSN 0006-291X; USA; DA. 1981; VOL. 101; NO 1; PP. 258-264; BIBL. 17 REF.Article

THE MOLECULAR COMPONENTS OF NITROFURANTOIN CRITICAL TO ITS INHIBITORY EFFECT UPON PLATELET AGGREGATION. = LES COMPOSANTS MOLECULAIRES DE LA NITROFURANTOINE CRITIQUES POUR SON EFFET INHIBITEUR SUR L'AGREGATION PLAQUETTAIREROSSI EC; MIEYAL JJ; STRONG JM et al.1975; MOLEC. PHARMACOL.; U.S.A.; DA. 1975; VOL. 11; NO 6; PP. 751-758; BIBL. 18 REF.Article

PLAQUETTES, ADP, AMP (C) ET DROGUES ANTIPLAQUETTAIRESGASCON G; TRUDEL J; RABBAT A et al.TRUDEL J; 1974; UN. MED. CANADA; CANADA; DA. 1974; VOL. 103; NO 6; PP. 1077-1082; ABS. ANGL.; BIBL. 22REF.Article

INHIBITION OF ADP-INDUCED PLATELET AGGREGATION BY FUROSEMIDE = INHIBITION DE L'AGREGATION PLAQUETTAIRE INDUITE PAR L'ADP PAR LE FUROSEMIDEROSSI EC; LEVIN NW.1973; J. LAB. CLIN. MED.; U.S.A.; DA. 1973; VOL. 81; NO 1; PP. 140-147; BIBL. 1 P.Serial Issue

EFFECT OF DRUG-INDUCED PLATELET DYSFUNCTION ON SURGICAL BLEEDINGKITCHEN L; ERICHSON RB; SIDEROPOULOS H et al.1982; AM. J. SURG.; ISSN 0002-9610; USA; DA. 1982-02; VOL. 143; PP. 215-217; BIBL. 4 REF.Article

ANTI-INFLAMMATORY AND PLATELET ANTI-AGGREGANT ACTIVITY OF PHOSPHOLIPASE-A₂ INHIBITORSVALLEE E; GOUGAT J; NAVARRO J et al.1979; J. PHARM. PHARMACOL.; GBR; DA. 1979; VOL. 31; NO 9; PP. 588-592; BIBL. 21 REF.Article

SULOCTIDIL: A NOVEL INHIBITOR OF PLATELET AGGREGATION IN HUMAN BEINGS = LE SULOCTIDIL, NOUVEL INHIBITEUR DE L'AGREGATION PLAQUETTAIRE CHEZ L'HOMMEDE GAETANO G; MIRAGLIOTTA G; RONCUCCI R et al.1976; THROMBOSIS RES.; G.B.; DA. 1976; VOL. 8; NO 3; PP. 361-371; BIBL. 1 P. 1/2Article

QUAND PRESCRIRE DES INHIBITEURS DES FONCTIONS PLAQUETTAIRES (OU ANTIAGREGANTS).DECHAVANNE M.1976; LYON MED.; FR.; DA. 1976; VOL. 235; NO 12; PP. 989-991; ABS. ANGL.; BIBL. 14 REF.Article

LA TERAPIA MEDICA DELLE IPOACUSIE RECETTIVE = LE TRAITEMENT MEDICAL DES HYPOACOUSIES DE RECEPTIONIANNETTI G.1973; MINERVA OTORINOLARINGOL.; ITAL.; DA. 1973; VOL. 23; NO 1; PP. 8-18; ABS. ANGL.; BIBL. 27 REF.Serial Issue

2.137.670 (B) (7216530). - 9MAI 1972. FLUORENYL-9 LACTAMIMIDES ET PROCEDE DE LEUR PREPARATIONsdPatent

LIPOXYGENASE INHIBITORS ALTER AGGREGATION AND ADHESIVENESS OF HUMAN BLOOD PLATELETS FROM ASPIRIN-TREATED PATIENTSGIMENO MF; SHATTNER MA; BORDA E et al.1983; PROSTAGLANDINS, LEUKOTRIENES AND MEDICINE; ISSN 0262-1746; GBR; DA. 1983; VOL. 11; NO 1; PP. 109-119; BIBL. 23 REF.Article

EXTENSIVE PHARYNGEAL HEMORRHAGE INDUCED BY DIPYRIDAMOLECOHEN AM; CRETER D; LEVINSKY UH et al.1981; ACTA HAEMATOL.; ISSN 0001-5792; CHE; DA. 1981; VOL. 66; NO 1; PP. 53-55; BIBL. 10 REF.Article

SUBSTITUTED 3,4-PENTADIENYLDIAMINES AS INHIBITORS OF PLATELET AGGREGATIONTILFORD CH; MACKENZIE RD; BLOHM TR et al.1973; J. MEDICIN. CHEM.; U.S.A.; DA. 1973; VOL. 16; NO 6; PP. 688-693; BIBL. 17REF.Serial Issue

LE ROLE DU MAGNESIUM VIS-A-VIS DE LA COAGULATION SANGUINEGIAFFERI D.1972; MED. INTERNE; FR.; DA. 1972; VOL. 7; NO 11; PP. 767-770; BIBL. 26REF.Serial Issue

2.132.838 (B) (72 12538). - 10AVRIL 1972. NOUVELLES PYRIDO(3,2-D) PYRIMIDINESsdPatent

INHIBITION OF AGGREGATION AND SECRETION OF HUMAN PLATELETS BY QUERCETIN AND OTHER FLAVONOIDS: STRUCTURE-ACTIVITY RELATIONSHIPSBERETZ A; CAZENAVE JP; ANTON R et al.1982; AGENTS AND ACTIONS; ISSN 0538-4818; CHE; DA. 1982; VOL. 12; NO 3; PP. 382-387; BIBL. 36 REF.Article

SERIES ON PHARMACOLOGY IN PRACTICE. X: ANTITHROMBOTIC THERAPY: ROLE OF PLATELET-INHIBITOR DRUGS. I: CURRENT CONCEPTS OF THROMBOGENESIS: ROLE OF PLATELETS (FIRST OF THREE PARTS)FUSTER V; CHESEBRO JH.1981; MAYO CLIN. PROC.; ISSN 0025-6196; USA; DA. 1981; VOL. 56; NO 1-2; PP. 102-112; BIBL. 199 REF.Article

PROSTAGLANDIN E₂ POTENTIATION OF PLATELET AGGREGATION INDUCED BY LASS ENDOPEROXIDE: ABSENT IN STORAGE POOL DISEASE, NORMAL AFTER ASPIRIN INGESTION.WEISS HJ; WILLIS AL; KUHN D et al.1976; BRIT. J. HAEMATOL.; G.B.; DA. 1976; VOL. 32; NO 2; PP. 257-272; BIBL. 1 P. 1/2Article

LES ANTI-AGREGANTS PLAQUETTAIRES. RESULTATS DES ESSAIS CLINIQUES.VERSTRAETE M.1976; CONCOURS MED.; FR.; DA. 1976; NO 39 SUPPL.; PP. 11-15; BIBL. 1 P. 1/2Article

PLATELET RELEASE AND AGGREGATION INDUCED BY ANTITHYMOCYTE GLOBULIN. IN VITRO EFFECT OF INHIBITORS. = LIBERATION ET AGREGATION DE PLAQUETTES INDUITES PAR GLOBULINE ANTI-THYMOCYTES. EFFET IN VITRO D'INHIBITEURSROSENBERG JC; SELL T.1975; TRANSPLANTATION; U.S.A.; DA. 1975; VOL. 20; NO 4; PP. 346-350; BIBL. 12 REF.Article

THE IN VITRO AND IN VIVO EVALUATION OF TILORONE HYDROCHLORIDE AS A PLATELET AGGREGATION INHIBITOR. = EVALUATION IN VITRO ET IN VIVO DU CHLORHYDRATE DE TILORONE COMME INHIBITEUR DE L'AGREGATION PLAQUETTAIREMACKENZIE RD; SCHATZMAN GL.1975; SCAND. J. HAEMATOL.; DENM.; DA. 1975; VOL. 15; NO 1; PP. 58-62; BIBL. 18 REF.Article